Illumina Stock Price To Sales
| ILMN Stock | USD 144.36 1.41 0.99% |
Illumina fundamentals help investors to digest information that contributes to Illumina's financial success or failures. It also enables traders to predict the movement of Illumina Stock. The fundamental analysis module provides a way to measure Illumina's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Illumina stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 4.75 | 4.51 |
Illumina | Price To Sales |
Illumina Company Price To Sales Analysis
Illumina's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Illumina Price To Sales | 5.16 X |
Most of Illumina's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Illumina is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Illumina Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Illumina is extremely important. It helps to project a fair market value of Illumina Stock properly, considering its historical fundamentals such as Price To Sales. Since Illumina's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Illumina's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Illumina's interrelated accounts and indicators.
Click cells to compare fundamentals
Illumina Price To Sales Historical Pattern
Today, most investors in Illumina Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Illumina's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Illumina price to sales as a starting point in their analysis.
Illumina Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Illumina Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Illumina has a Price To Sales of 5.1644 times. This is 75.87% lower than that of the Life Sciences Tools & Services sector and 55.52% lower than that of the Health Care industry. The price to sales for all United States stocks is 54.78% higher than that of the company.
Illumina Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Illumina's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics of similar companies.Illumina is currently under evaluation in price to sales category among its peers.
Illumina ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.Environmental | Governance | Social |
Illumina Fundamentals
| Return On Equity | -0.4 | ||||
| Return On Asset | 0.0262 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 24.54 B | ||||
| Shares Outstanding | 158.6 M | ||||
| Shares Owned By Insiders | 0.27 % | ||||
| Shares Owned By Institutions | 95.17 % | ||||
| Number Of Shares Shorted | 6.72 M | ||||
| Price To Earning | 49.12 X | ||||
| Price To Book | 10.73 X | ||||
| Price To Sales | 5.16 X | ||||
| Revenue | 4.5 B | ||||
| Gross Profit | 3.15 B | ||||
| EBITDA | (1.07 B) | ||||
| Net Income | (1.16 B) | ||||
| Cash And Equivalents | 2.01 B | ||||
| Cash Per Share | 6.62 X | ||||
| Total Debt | 2.26 B | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 0.93 X | ||||
| Book Value Per Share | 13.45 X | ||||
| Cash Flow From Operations | 478 M | ||||
| Short Ratio | 3.97 X | ||||
| Earnings Per Share | (9.97) X | ||||
| Price To Earnings To Growth | 0.62 X | ||||
| Target Price | 164.6 | ||||
| Number Of Employees | 10.59 K | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 22.67 B | ||||
| Total Asset | 10.11 B | ||||
| Retained Earnings | (19 M) | ||||
| Working Capital | 1.04 B | ||||
| Current Asset | 2.1 B | ||||
| Current Liabilities | 610.49 M | ||||
| Net Asset | 10.11 B |
About Illumina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving together with Illumina Stock
Moving against Illumina Stock
| 0.77 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.65 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.63 | ICU | LMF Acquisition Oppo | PairCorr |
| 0.5 | VALN | Valneva SE ADR | PairCorr |
| 0.48 | VRAX | Virax Biolabs Group | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Illumina Piotroski F Score and Illumina Altman Z Score analysis. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.97) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.